Gurtsevitch et al. [39] discovered in non-endemic NPC locations that all cases of undifferentiated or poorly differentiated NPC have high amounts of IgA antibodies specific to conventional EBV markers. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.